Patients getting faster access to cancer drugs as NICE approves three quarters of the Cancer Drugs Fund
Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.
Thousands more people could be offered drugs to prevent bone fractures because of osteoporosis
NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.
Pancreatic cancer patients to have routine access to life extending drug after new deal, says NICE
NICE has recommended nab-paclitaxel for routine NHS use after the company agreed a confidential price discount and provided more evidence on its effectiveness.
Roche invited to submit a CDF proposal for urothelial cancer drug
NICE has asked Roche to submit a Cancer Drugs Fund (CDF) proposal for an immunotherapy treatment called atezolizumab.
Latest news headlines
-
Autistic people will receive better care if GPs develop a national register, says NICE
NICE is calling on GPs to develop a national autism register to ensure autistic people receive the tailored care they need.
01 August 2017
-
Statins should be offered to everyone who has chronic kidney disease, says NICE
Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD). This will help to manage their increased risk of cardiovascular disease (CVD), says NICE.
27 July 2017
-
£3 a day drug for irritable bowel syndrome gets NICE approval
The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable bowel syndrome and diarrhoea (IBS-D).
27 July 2017
-
New NICE advice about when to give antibiotics for common infections
For the first time NICE is giving specific advice for doctors and nurses about when and how to prescribe antibiotics for conditions such as sore throats and colds.
27 July 2017
-
NICE approval for nivolumab provides new treatment for advanced blood cancer
People with an advanced type of blood cancer will benefit from nivolumab on the NHS following approval by NICE.
26 July 2017
-
Managing conflicts of interest – making good decisions
NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions are fair and unbiased.
24 July 2017